Notably, epigallocatechin gallate (EGCG) can activate Nrf2 expression and function, effectively mitigating diabetes-induced renal oxidative damage, inflammation, fibrosis, and proteinuria [45]. Here, NFE2L2 is linked to diabetes mellitus.